Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 47

Results For "ABI"

4530 News Found

Plus Therapeutics subsidiary clears key Medicare milestone
News | May 12, 2026

Plus Therapeutics subsidiary clears key Medicare milestone

Paves way for CNS cancer test rollout


P. D. Hinduja Hospital introduces CORI robotic-assisted system for knee and hip replacement
Hospitals | May 12, 2026

P. D. Hinduja Hospital introduces CORI robotic-assisted system for knee and hip replacement

Advanced image-free robotic platform to support greater precision, personalised planning, and improved patient outcomes


FDA okays RIVANNA’s AI-powered Accuro XV ultrasound system
Medical Device | May 12, 2026

FDA okays RIVANNA’s AI-powered Accuro XV ultrasound system

The clearance marks a pivotal step forward for the company as it pushes deeper into AI-driven diagnostics and expands its clinical footprint in point-of-care imaging


CORONA Remedies posts robust FY26 with 17.3% revenue growth, 33.4% PAT surge
News | May 12, 2026

CORONA Remedies posts robust FY26 with 17.3% revenue growth, 33.4% PAT surge

The company highlighted a series of strategic moves during the year, including the acquisition of WOKADINE, marking its entry into the Rs. 648 Cr Povidone Iodine market


JB Chemicals reports muted Q4 FY26 as integration resets business
News | May 12, 2026

JB Chemicals reports muted Q4 FY26 as integration resets business

The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year


Shareholders approve J.B. Pharma merger with Torrent Pharma
News | May 12, 2026

Shareholders approve J.B. Pharma merger with Torrent Pharma

Proposed amalgamation now awaits NCLT approval; shareholders to receive 51 Torrent Pharma shares for every 100 JB Pharma shares held


HealthQuad invests in AI-powered LifeSigns
Digitisation | May 12, 2026

HealthQuad invests in AI-powered LifeSigns

Investment will support LifeSigns’ global expansion across Southeast Asia and GCC markets


Bajaj Healthcare FY26 revenue rises 12.6% to Rs 6,110 million
News | May 11, 2026

Bajaj Healthcare FY26 revenue rises 12.6% to Rs 6,110 million

Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint


FUJIFILM Biosciences & NextCell launch platform to standardize regenerative medicine development
R&D | May 11, 2026

FUJIFILM Biosciences & NextCell launch platform to standardize regenerative medicine development

The move targets long-standing bottlenecks in MSC science, including cell-to-cell variability, immunocompatibility concerns, and inefficient manufacturing workflows